128 related articles for article (PubMed ID: 9600369)
1. Tamoxifen does not improve survival of patients with advanced hepatocellular carcinoma.
Riestra S; Rodriguez M; Delgado M; Suárez A; González N; de la Mata M; Diaz G; Miño-Fugarolas G; Rodrigo L
J Clin Gastroenterol; 1998 Apr; 26(3):200-3. PubMed ID: 9600369
[TBL] [Abstract][Full Text] [Related]
2. Treatment of hepatocellular carcinoma with tamoxifen: a double-blind placebo-controlled trial in 120 patients.
Castells A; Bruix J; Brú C; Ayuso C; Roca M; Boix L; Vilana R; Rodés J
Gastroenterology; 1995 Sep; 109(3):917-22. PubMed ID: 7657122
[TBL] [Abstract][Full Text] [Related]
3. Treatment of hepatocellular carcinoma with combined suppression and inhibition of sex hormones: a randomized, controlled trial.
Manesis EK; Giannoulis G; Zoumboulis P; Vafiadou I; Hadziyannis SJ
Hepatology; 1995 Jun; 21(6):1535-42. PubMed ID: 7768497
[TBL] [Abstract][Full Text] [Related]
4. Tamoxifen combined with octreotide or regular chemotherapeutic agents in treatment of primary liver cancer: a randomized controlled trial.
Pan DY; Qiao JG; Chen JW; Huo YC; Zhou YK; Shi HA
Hepatobiliary Pancreat Dis Int; 2003 May; 2(2):211-5. PubMed ID: 14599971
[TBL] [Abstract][Full Text] [Related]
5. High-dose tamoxifen in the treatment of inoperable hepatocellular carcinoma: A multicenter randomized controlled trial.
Chow PK; Tai BC; Tan CK; Machin D; Win KM; Johnson PJ; Soo KC;
Hepatology; 2002 Nov; 36(5):1221-6. PubMed ID: 12395333
[TBL] [Abstract][Full Text] [Related]
6. Randomized trial of leuprorelin and flutamide in male patients with hepatocellular carcinoma treated with tamoxifen.
Groupe d'Etude et de Traitement du Carcinome Hépatocellulaire
Hepatology; 2004 Dec; 40(6):1361-9. PubMed ID: 15565568
[TBL] [Abstract][Full Text] [Related]
7. Treatment of advanced hepatocellular carcinoma with tamoxifen and the correlation with expression of hormone receptors: a prospective randomized study.
Liu CL; Fan ST; Ng IO; Lo CM; Poon RT; Wong J
Am J Gastroenterol; 2000 Jan; 95(1):218-22. PubMed ID: 10638587
[TBL] [Abstract][Full Text] [Related]
8. Randomized controlled trial of tamoxifen in advanced hepatocellular carcinoma.
Barbare JC; Bouché O; Bonnetain F; Raoul JL; Rougier P; Abergel A; Boige V; Denis B; Blanchi A; Pariente A; Milan C; Bedenne L
J Clin Oncol; 2005 Jul; 23(19):4338-46. PubMed ID: 15994145
[TBL] [Abstract][Full Text] [Related]
9. Phase II study of combination doxorubicin, interferon-alpha, and high-dose tamoxifen treatment for advanced hepatocellular carcinoma.
Lu YS; Hsu C; Li CC; Kuo SH; Yeh KH; Yang CH; Hsu CH; Wu CY; Cheng AL
Hepatogastroenterology; 2004; 51(57):815-9. PubMed ID: 15143923
[TBL] [Abstract][Full Text] [Related]
10. Randomized controlled trial of tamoxifen versus placebo in inoperable hepatocellular carcinoma.
Elba S; Giannuzzi V; Misciagna G; Manghisi OG
Ital J Gastroenterol; 1994 Mar; 26(2):66-8. PubMed ID: 8032079
[TBL] [Abstract][Full Text] [Related]
11. Tamoxifen does not improve overall survival in people with advanced-stage hepatocellular carcinoma.
Chow PK
Cancer Treat Rev; 2005 Oct; 31(6):491-5. PubMed ID: 16214294
[No Abstract] [Full Text] [Related]
12. Controlled trial of tamoxifen in patients with advanced hepatocellular carcinoma.
Martínez Cerezo FJ; Tomás A; Donoso L; Enríquez J; Guarner C; Balanzó J; Martínez Nogueras A; Vilardell F
J Hepatol; 1994 Jun; 20(6):702-6. PubMed ID: 7930468
[TBL] [Abstract][Full Text] [Related]
13. Tamoxifen for hepatocellular carcinoma.
Nowak A; Findlay M; Culjak G; Stockler M
Cochrane Database Syst Rev; 2004; (3):CD001024. PubMed ID: 15266436
[TBL] [Abstract][Full Text] [Related]
14. Ramucirumab versus placebo as second-line treatment in patients with advanced hepatocellular carcinoma following first-line therapy with sorafenib (REACH): a randomised, double-blind, multicentre, phase 3 trial.
Zhu AX; Park JO; Ryoo BY; Yen CJ; Poon R; Pastorelli D; Blanc JF; Chung HC; Baron AD; Pfiffer TE; Okusaka T; Kubackova K; Trojan J; Sastre J; Chau I; Chang SC; Abada PB; Yang L; Schwartz JD; Kudo M;
Lancet Oncol; 2015 Jul; 16(7):859-70. PubMed ID: 26095784
[TBL] [Abstract][Full Text] [Related]
15. Biochemical modulation of doxorubicin by high-dose tamoxifen in the treatment of advanced hepatocellular carcinoma.
Cheng AL; Yeh KH; Fine RL; Chuang SE; Yang CH; Wang LH; Chen DS
Hepatogastroenterology; 1998; 45(24):1955-60. PubMed ID: 9951847
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of selective internal radiotherapy with yttrium-90 resin microspheres compared with sorafenib in locally advanced and inoperable hepatocellular carcinoma (SARAH): an open-label randomised controlled phase 3 trial.
Vilgrain V; Pereira H; Assenat E; Guiu B; Ilonca AD; Pageaux GP; Sibert A; Bouattour M; Lebtahi R; Allaham W; Barraud H; Laurent V; Mathias E; Bronowicki JP; Tasu JP; Perdrisot R; Silvain C; Gerolami R; Mundler O; Seitz JF; Vidal V; Aubé C; Oberti F; Couturier O; Brenot-Rossi I; Raoul JL; Sarran A; Costentin C; Itti E; Luciani A; Adam R; Lewin M; Samuel D; Ronot M; Dinut A; Castera L; Chatellier G;
Lancet Oncol; 2017 Dec; 18(12):1624-1636. PubMed ID: 29107679
[TBL] [Abstract][Full Text] [Related]
17. Use of tamoxifen in advanced-stage hepatocellular carcinoma. A systematic review.
Nowak AK; Stockler MR; Chow PK; Findlay M
Cancer; 2005 Apr; 103(7):1408-14. PubMed ID: 15744746
[TBL] [Abstract][Full Text] [Related]
18. Hepatocellular carcinoma. Prognostic factors and survival analysis in 135 Italian patients.
Rosellini SR; Arienti V; Nanni O; Ugenti F; Tassinari M; Camporesi C; Boriani L; Versari G; Costa PL; Amadori D
J Hepatol; 1992 Sep; 16(1-2):66-72. PubMed ID: 1336513
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of the combination of long-acting release octreotide and tamoxifen in patients with advanced hepatocellular carcinoma: a randomised multicentre phase III study.
Verset G; Verslype C; Reynaert H; Borbath I; Langlet P; Vandebroek A; Peeters M; Houbiers G; Francque S; Arvanitakis M; Van Laethem JL
Br J Cancer; 2007 Sep; 97(5):582-8. PubMed ID: 17687341
[TBL] [Abstract][Full Text] [Related]
20. Regression of a hepatocellular carcinoma following treatment with octreotide and tamoxifen in a patient with advanced alcoholic cirrhosis.
Senturk H; Canbakan B; Cumali R
J Gastroenterol Hepatol; 2004 Jun; 19(6):719-20. PubMed ID: 15151636
[No Abstract] [Full Text] [Related]
[Next] [New Search]
